PDS Biotechnology Corporation

NASDAQ: PDSB
Share price (1/7/25): $1.68
Market cap (1/7/25): $62.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Shelf registration

Ownership Filter

Freitag Gregory Gene

Glover Stephen C.

News Filter

Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results

Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated With Versamune® HPV and Chemoradiation

Investor Presentation

Biotech Announces Updated Results From VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024

Material Definitive Agreement, Termination of Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC